Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
90.61
+4.65 (5.41%)
Nov 21, 2024, 1:14 PM EST - Market open
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $11.29 billion as of November 21, 2024. Its market cap has increased by 136.19% in one year.
Market Cap
11.29B
Enterprise Value
8.56B
1-Year Change
136.19%
Ranking
Category
Stock Price
$90.61
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $11.29B, an increase of 718.38%. That is a compound annual growth rate of 60.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 10.71B | 79.29% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 11.78B |
| Solventum | 11.60B |
| Globus Medical | 11.14B |
| AptarGroup | 11.09B |
| Smith & Nephew | 10.81B |
| Catalent | 10.67B |
| Bio-Techne | 10.62B |
| Sarepta Therapeutics | 10.00B |